‹ All Posts
Akshay Patel

12th Mar · SEBI-Registered Analyst

BIOCON
reported strong Q3FY26 results with consolidated revenue growing 9.2% YoY to ₹41,730 million. Net profit attributable to shareholders surged to ₹1,438 million from ₹251 million, while basic EPS improved significantly to ₹1.08. Nine-month revenue reached ₹1,24,104 million with net profit of ₹2,597 million, reflecting the company's operational strength and market expansion. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.

#TrendingSectors#Miscellaneous
836 likes·29 comments